Related Experiment Video
Updated: Feb 25, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.6K
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
Cristina Santoro1, Paola Volpicelli1, Erminia Baldacci1
1Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
Clinical Case Reports
|August 8, 2017
Abstract:
Thrombopoietin receptor agonists (TPO-RAs) are used as effective alternative treatments in ITP patients unresponsive to first-/second-line therapies. TPO-RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO-RAs can be suspended maintaining a sustained response.
